Effect of Omega-3 Fatty Acids on Plasma Level of 8-Isoprostane in Kidney Transplant Patients

Journal of Renal Nutrition

Volumn 21, Issue 2, 2011, Pages 196-199

  Ramezani, Mohammad ^a   Nazemian, Fatemeh ^b   Shamsara, Jamal ^c   Koohrokhi, Reza ^c   Mohammadpour, Amir Hooshang ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE; FISH OIL; ISOPROSTANE DERIVATIVE; OMEGA 3 FATTY ACID; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE BLIND PROCEDURE;

ADULT; DINOPROST; F2-ISOPROSTANES; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 79951581771     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.06.023     Document Type: Article

References (26)

1. Marcen R. Cardiovascular risk factors in renal transplantation-current controversies. Nephrol Dial Transplant 2006, 21(Suppl 3):iii3-iii8.
2. Ostovan M.A., Fazelzadeh A., Mehdizadeh A.R., et al. How to decrease cardiovascular mortality in renal transplant recipients. Transplant Proc 2006, 38:2887-2892.
3. Biernacki M., Bigda J., Jankowski K., et al. Increased serum levels of markers of oxidative stress during kidney transplantation. Transplant Proc 2002, 34:544-545.
4. Spittle M.A., Hoenich N.A., Handelman G.J., et al. Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis 2001, 38:1408-1413.
5. Palombo C., Lubrano V., Sampietro T. Oxidative stress, F2-isoprostanes and endothelial dysfunction in hypercholesterolemia. Cardiovasc Res 1999, 44:474-476.
6. Morrow J.D., Frei B., Longmire A.W., et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995, 332:1198-1203.
7. Gong Y., Yi M., Fediuk J., et al. Hypoxic neonatal pulmonary arterial myocytes are sensitized to ROS-generated 8-isoprostane. Free Radic Biol Med 2010, 48:882-894.
8. Morrow J.D., Minton T.A., Badr K.F., et al. Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo. Biochim Biophys Acta 1994, 1210:244-248.
9. Clarke D.L., Dakshinamurti S., Larsson A.K., et al. Lipid metabolites as regulators of airway smooth muscle function. Pulm Pharmacol Ther 2009, 22:426-435.
10. Delanty N., Reilly M., Pratico D., et al. 8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br J Clin Pharmacol 1996, 42:15-19.
11. Taziki O., Lessan-Pezeshki M., Akha O., et al. The effect of low dose omega-3 on plasma lipids in hemodialysis patients. Saudi J Kidney Dis Transpl 2007, 18:571-576.
12. Saifullah A., Watkins B.A., Saha C., et al. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients-a pilot study. Nephrol Dial Transplant 2007, 22:3561-3567.
13. Hau M.-F., Smelt A.H., Bindels A.J., et al. Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol 1996, 16:1197-1202.
14. Sorensen N.S., Marckmann P., Hoy C.E., et al. Effect of fish-oil-enriched margarine on plasma lipids, low-density- lipoprotein particle composition, size, and susceptibility to oxidation. Am J Clin Nutr 1998, 68:235-241.
15. Tatsioni A., Chung M., Sun Y., et al. Effects of fish oil supplementation on kidney transplantation: a systematic review and meta-analysis of randomized, controlled trials. J Am Soc Nephrol 2005, 16:2462-2470.
16. Lim A.K., Manley K.J., Roberts M.A., et al. Fish oil for kidney transplant recipients. Cochrane Database Syst Rev 2007, 18:CD005282.
17. Castro R., Queiros J., Fonseca I., et al. Therapy of post-renal transplantation hyperlipidaemia: comparative study with simvastatin and fish oil. Nephrol Dial Transplant 1997, 12:2140-2143.
18. Grekas D., Kassimatis E., Makedou A., et al. Combined treatment with low-dose pravastatin and fish oil in post-renal transplantation dislipidemia. Nephron 2001, 88:329-333.
19. Friedman A., Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol 2006, 1:182-192.
20. Mazza M., Pomponi M., Janiri L., et al. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:12-26.
21. Barbosa D.S., Cecchini R., El Kadri M.Z., et al. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 2003, 19:837-842.
22. Jain S., Gaiha M., Bhattacharjee J., et al. Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress-a prospective preliminary study. J Assoc Physicians India 2002, 50:1028-1033.
23. Mori T.A. Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation. Redox Rep 2004, 9:193-197.
24. Mori T.A., Puddey I.B., Burke V., et al. Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion. Redox Rep 2000, 5:45-46.
25. Nalsen C., Vessby B., Berglund L., et al. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans. J Nutr 2006, 136:1222-1228.
26. Holm T., Andreassen A.K., Aukrust P., et al. Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients. Eur Heart J 2001, 22:428-436.